PME · ASX

Pro Medicus, Ltd. (ASX:PME)

AU$214.62

 0.0 (0.0%)
ASX:Live
21/11/2024 04:10:42 PM
Short Term Trend - Long Near Resistance Near 52 Week High Hammer Bearish HALO Price Momentum +15
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PME Overview

PME Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Weak

Event

Very Weak

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About PME

Website

Pro Medicus, Ltd.

Telephone

61.3.9429.8800

Address

450 Swan Street Richmond, Victoria (VIC) 3121

Description

Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. It provides services in the form of installation and support. The firm offers a range of products including radiology information systems, picture archiving and communication systems. It also offers workflow mapping and optimization, network design and implementation, hardware sourcing, and configuration as well as staff and management training. The company was founded by Sam Aaron Hupert and Anthony Barry Hall in 1983 and is headquartered in Richmond, Australia.

PME Price Chart

Key Stats

Market Cap

AU$22.22B

PE

173.50

EV/EBITDA

116.5

Dividends Overview

DIV Yield

.3%

Franking

100%

Ex Dividend Date (est.)

04-Sep-24

Market Data

52 weeks range

Low 85.6 - 215.34

Trade Value (12mth)

AU$9,183,193.00

1 week

2.27%

1 month

9.87%

YTD

122.87%

1 year

140.96%

All time high

215.34

Key Fundamentals

EPS 3 yr Growth

167.60%

EBITDA Margin

74.80%

Operating Cashflow

$87m

Free Cash Flow Return

52.70%

ROIC

50.30%

Interest Coverage

N/A

Quick Ratio

6.00

Other Data

Shares on Issue (Fully Dilluted)

105m

HALO Sector

Healthcare

Next Company Report Date

13-Aug-25

Ex Dividend Date (est.)

04-Sep-24

Next Dividend Pay Date (est.)

26-Sep-24

Reporting Currency

AUD

Short Sell (% of issue)

2.20

PME Announcements

Latest Announcements

Date Announcements

30 October 24

Change of Director's Interest Notice - Alice Williams

×

Change of Director's Interest Notice - Alice Williams

24 October 24

Notice of Annual General Meeting and Proxy Form

×

Notice of Annual General Meeting and Proxy Form

24 October 24

PME Annual General Meeting virtual online guide

×

PME Annual General Meeting virtual online guide

16 October 24

PME signs $32M, 5-year contract extension in Australia

×

PME signs $32M, 5-year contract extension in Australia

08 October 24

AGM Date

×

AGM Date

07 October 24

PME signs A$98M, 8 year contract renewal with Mercy Health

×

PME signs A$98M, 8 year contract renewal with Mercy Health

13 September 24

Change of Director's Interest Notice - Anthony Hall

×

Change of Director's Interest Notice - Anthony Hall

26 August 24

Application for quotation of securities - PME

×

Application for quotation of securities - PME

26 August 24

Notification of cessation of securities - PME

×

Notification of cessation of securities - PME

26 August 24

Change of Director's Interest Notice - Alice Williams

×

Change of Director's Interest Notice - Alice Williams

26 August 24

Notification regarding unquoted securities - PME

×

Notification regarding unquoted securities - PME

26 August 24

Notification regarding unquoted securities - PME

×

Notification regarding unquoted securities - PME

26 August 24

Notification regarding unquoted securities - PME

×

Notification regarding unquoted securities - PME

26 August 24

Notification of cessation of securities - PME

×

Notification of cessation of securities - PME

14 August 24

Preliminary Final Report

×

Preliminary Final Report

14 August 24

PME Full Year Results

×

PME Full Year Results

14 August 24

Annual Report 2024

×

Annual Report 2024

14 August 24

Appendix 4G

×

Appendix 4G

14 August 24

2024 Corporate Governance Statement

×

2024 Corporate Governance Statement

14 August 24

Dividend/Distribution - PME

×

Dividend/Distribution - PME

14 August 24

CEO Interview - FY results

×

CEO Interview - FY results

14 August 24

PME FY2024 results presentation

×

PME FY2024 results presentation

12 July 24

PME FY24 Results release date and webcast briefing

×

PME FY24 Results release date and webcast briefing

28 May 24

PME signs five new deals with a combined minimum of A$45M

×

PME signs five new deals with a combined minimum of A$45M

08 May 24

Macquarie Conference May 2024 Presentation

×

Macquarie Conference May 2024 Presentation

PME Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.43 0.58 0.79 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.42 0.58 0.79 Lock Lock Lock
     Growth % Lock Lock Lock Lock 43.8 36.4 36.5 Lock Lock Lock
     PE X Lock Lock Lock Lock 124.7 124.4 173.5 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 80.4 79.8 116.5 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.51 0.68 0.91 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.41 0.37 0.48 Lock Lock Lock
     Growth % Lock Lock Lock Lock 33.5 33.5 34.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.0 0.6 0.3 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.22 0.30 0.40 Lock Lock Lock
     Growth % Lock Lock Lock Lock 46.7 36.4 33.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.4 0.4 0.3 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 52 52 50 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.98 1.33 1.80 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.76 1.12 1.61 Lock Lock Lock
     Growth % Lock Lock Lock Lock 28.7 47.6 42.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 105 105 105 Lock Lock Lock
Basic m Lock Lock Lock Lock 104 104 104 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 93 125 162 Lock Lock Lock
     Growth % Lock Lock Lock Lock 37.7 33.6 29.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 8 8 10 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 70 92 122 Lock Lock Lock
     Growth % Lock Lock Lock Lock 50.6 31.4 32.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 75.2 74.0 75.7 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 25 26 24 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 70 92 121 Lock Lock Lock
     Growth % Lock Lock Lock Lock 40.6 31.7 31.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 74.6 73.5 74.8 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 7 8 9 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 62 84 112 Lock Lock Lock
     Growth % Lock Lock Lock Lock 47.2 34.4 33.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 66.8 67.2 69.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 63 86 116 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 19 25 34 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 44 61 83 Lock Lock Lock
     Growth % Lock Lock Lock Lock 44.1 36.5 36.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 47.6 48.6 51.3 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 62 65 87 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 9 6 7 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -18 -10 -78 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -23 -28 -40 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 62 64 86 Lock Lock Lock
     Growth % Lock Lock Lock Lock 59.4 4.0 34.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.7 0.5 0.5 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 5 13 24 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 91 121 155 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 157 202 257 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 2 1 2 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -88 -120 -153 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 55 63 70 Lock Lock Lock
Equity $m Lock Lock Lock Lock 102 139 188 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 103 140 189 Lock Lock Lock
     Growth % Lock Lock Lock Lock 23.5 35.4 35.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 28.3 30.0 32.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 43.7 43.7 44.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 66.3 68.6 67.9 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 47.5 49.8 50.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 66.5 53.2 52.7 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -1.3 -1.3 -1.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -86.8 -86.2 -81.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 4.5 5.3 6.0 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.5 5.3 6.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 75.6 74.2 75.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 231.7 210.0 251.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.6 3.6 3.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 417.7 493.0 753.7 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.0 0.9 0.9 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 1.8 0.8 1.1 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.6 0.6 0.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.6 0.6 0.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 67.5 69.0 72.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 40.2 42.6 45.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 29.5 29.6 28.9 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 28.3 30.0 32.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.5 1.5 1.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 43.7 43.7 44.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 48.4 48.4 49.5 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 21.1 21.1 21.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.9 0.7 0.5 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 102.1 100.2 101.5 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 103.0 100.9 102.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 19.8 15.0 12.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 83.2 85.9 89.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

04-Sep-24

DIV Yield

.3%

Franking Level

100%

DPSg

33.30%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

2.20%

Value ($M)

470

Prior Change

N/A

7 Day Change

-0.10%

1 Month Change

-0.50%

3 Month Change

-0.50%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PME Shortsell

Frequently Asked Questions

The current share price of Pro Medicus, Ltd. (PME:ASX) is AU$214.62.
The 52-week high share price for Pro Medicus, Ltd. (PME:ASX) is AU$215.34.
The 52-week low share price for Pro Medicus, Ltd. (PME:ASX)? is AU$85.60.
The current TTM dividend payout for Pro Medicus, Ltd. (PME:ASX) is 0.30.
The last dividend payment of Pro Medicus, Ltd. (PME:ASX) is AU$0.22.
Pro Medicus, Ltd. (PME:ASX) has a franking level of 100.0%.
Pro Medicus, Ltd. (PME:ASX) is classified in the Healthcare.
The current P/E ratio for Pro Medicus, Ltd. (PME:ASX) is 173.50.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.